| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.28 |
1e-09 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-08 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-07 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-07 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |